Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 971982, 9 pages
http://dx.doi.org/10.1155/2015/971982
Research Article

Acute and Chronic Toxicity, Cytochrome P450 Enzyme Inhibition, and hERG Channel Blockade Studies with a Polyherbal, Ayurvedic Formulation for Inflammation

1Bioved Pharmaceuticals Pvt. Ltd., BAIF Bhawan, Z Wing, Warje Malwadi, Pune 411 052, India
2Bioved Pharmaceuticals, Inc., 1929 O’Toole Way, San Jose, CA 95131, USA

Received 16 December 2014; Revised 20 February 2015; Accepted 20 February 2015

Academic Editor: Khac-Minh Thai

Copyright © 2015 Debendranath Dey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Vora and G. A. Mansoor, “Herbs and alternative therapies: relevance to hypertension and cardiovascular diseases,” Current Hypertension Reports, vol. 7, no. 4, pp. 275–280, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Schoepfer, A. Engel, K. Fattinger et al., “Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products,” Journal of Hepatology, vol. 47, no. 4, pp. 521–526, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Michalsen, “The role of complementary and alternative medicine (CAM) in rheumatology—it's time for integrative medicine,” The Journal of Rheumatology, vol. 40, no. 5, pp. 547–549, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Firenzuoli and L. Gori, “Herbal medicine today: clinical and research issues,” Evidence-Based Complementary and Alternative Medicine, vol. 4, supplement 1, pp. 37–40, 2007. View at Publisher · View at Google Scholar
  5. P. A. Cohen, “Hazards of hindsight—monitoring the safety of nutritional supplements,” The New England Journal of Medicine, vol. 370, no. 14, pp. 1277–1280, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Lahlou, Z. H. Israili, and B. Lyoussi, “Acute and chronic toxicity of a lyophilised aqueous extract of Tanacetum vulgare leaves in rodents,” Journal of Ethnopharmacology, vol. 117, no. 2, pp. 221–227, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Ha, J. K. Lee, H. Y. Lee et al., “Evaluation of safety of the herbal formula Ojeok-san: acute and sub-chronic toxicity studies in rats,” Journal of Ethnopharmacology, vol. 131, no. 2, pp. 410–416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Wanga, J. Liub, B. Zhoub et al., “Acute and sub-chronic toxicity studies of Danshen injection in Sprague-Dawley rats,” Journal of Ethnopharmacology, vol. 141, no. 1, pp. 96–103, 2012. View at Publisher · View at Google Scholar
  9. P. Scartezzini and E. Speroni, “Review on some plants of Indian traditional medicine with antioxidant activity,” Journal of Ethnopharmacology, vol. 71, no. 1-2, pp. 23–43, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. I. Thabrew, L. Senaratna, N. Samarawickrema, and C. Munasinghe, “Antioxidant potential of two polyherbal. Preparations used in Ayurveda for the treatment of rheumatoid arthritis,” Journal of Ethnopharmacology, vol. 76, no. 3, pp. 285–291, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Chopra, J. Patil, V. Doiphode, and B. Patwardhan, “Exploring ancient Ayurveda for rheumatology; traditional therapy, modern relevance and challenges,” APLAR Journal of Rheumatology, vol. 4, pp. 190–199, 2001. View at Google Scholar
  12. S. Dugasani, M. R. Pichika, V. D. Nadarajah, M. K. Balijepalli, S. Tandra, and J. N. Korlakunta, “Comparative antioxidant and anti-inflammatory effects of [6]-gingerol, [8]-gingerol, [10]-gingerol and [6]-shogaol,” Journal of Ethnopharmacology, vol. 127, no. 2, pp. 515–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Chopra, P. Lavin, B. Patwardhan, and D. Chitre, “Randomized double blind trial of an Ayurvedic plant derived formulation for treatment of rheumatoid arthritis,” Journal of Rheumatology, vol. 27, no. 6, pp. 1365–1372, 2000. View at Google Scholar · View at Scopus
  14. A. Chopra, P. Lavin, B. Patwardhan, and D. Chitre, “A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees,” Journal of Clinical Rheumatology, vol. 10, no. 5, pp. 236–245, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Dey, S. Chaskar, N. Athavale, and D. Chitre, “Inhibition of LPS-Induced TNF-α and NO production in mouse macrophage and inflammatory response in rat animal models by a novel ayurvedic formulation, BV-9238,” Phytotherapy Research, vol. 28, no. 10, pp. 1479–1485, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. T. I. Bongartz, A. J. Sutton, M. J. Sweeting, I. Buchan, E. L. Matteson, and V. Montori, “Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials,” The Journal of the American Medical Association, vol. 295, no. 19, pp. 2275–2285, 2006. View at Google Scholar
  17. S. Bernatsky, D. Feldman, M. De Civita et al., “Optimal care for rheumatoid arthritis: a focus group study,” Clinical Rheumatology, vol. 29, no. 6, pp. 645–657, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. R. S. Obach, “Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression,” Journal of Pharmacology and Experimental Therapeutics, vol. 294, no. 1, pp. 88–95, 2000. View at Google Scholar · View at Scopus
  19. C. Tang, M. Shou, Q. Mei, T. H. Rushmore, and A. D. Rodrigues, “Major role of human liver microsomal cytochrome P450 2C9 (CYP2C9) in the oxidative metabolism of celecoxib, a novel cyclooxygenase-II inhibitor,” Journal of Pharmacology and Experimental Therapeutics, vol. 293, no. 2, pp. 453–459, 2000. View at Google Scholar · View at Scopus
  20. R. Delgoda and A. C. G. Westlake, “Herbal interactions involving cytochrome P450 enzymes,” Toxicological Reviews, vol. 23, no. 4, pp. 239–249, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Zhou, Y. Gao, W. Jiang, M. Huang, A. Xu, and J. W. Paxton, “Interactions of herbs with cytochrome P450,” Drug Metabolism Reviews, vol. 35, no. 1, pp. 35–98, 2003. View at Google Scholar · View at Scopus
  22. M. Ekor, “The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety,” Frontiers in Neurology, vol. 4, article 177, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. C. M. Pratt, H. R. Al-Khalidi, J. M. Brum et al., “Cumulative experience of azimilide associated torsades de pointes ventricular tachycardia in the 19 clinical studies comprising the azimilide database,” Journal of the American College of Cardiology, vol. 48, no. 3, pp. 471–477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Darpo, “Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes,” European Heart Journal, vol. 3, pp. 70–80, 2001. View at Google Scholar
  25. D. Justo, V. Prokhorov, K. Heller, and D. Zeltser, “Torsade de pointes induced by psychotropic drugs and the prevalence of its risk factors,” Acta Psychiatrica Scandinavica, vol. 111, no. 3, pp. 171–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. M. C. Sanguinetti and M. Tristani-Firouzi, “hERG potassium channels and cardiac arrhythmia,” Nature, vol. 440, no. 7083, pp. 463–469, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. Chitre and D. Dey, “Novel formulations to inhibit cyclooxygenase and pro-inflammatory cytokine mediated diseases,” US Patent Application Publication 2010/0150865 A1, 2010. View at Google Scholar
  28. P. K. Chan, G. P. O'Hara, and A. W. Hayes, “Principles and methods for acute and subchronic toxicity,” in Principles and Methods of Toxicology, A. W. Hayes, Ed., pp. 17–19, Raven Press, New York, NY, USA, 1982. View at Google Scholar
  29. B. F. Feldman, J. G. Zinkl, N. C. Jain, and D. M. Moor, Schalm's Veterinary Hematology, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 5th edition, 2000.
  30. C. L. Crespi, V. P. Miller, and B. W. Penman, “Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450,” Analytical Biochemistry, vol. 248, no. 1, pp. 188–190, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. B. D. Marks, R. W. Smith, H. A. Braun et al., “A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrate,” ASSAY and Drug Development Technologies, vol. 1, no. 1, pp. 73–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. Z. Zhou, Q. Gong, B. Ye et al., “Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature,” Biophysical Journal, vol. 74, no. 1, pp. 230–241, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Finlayson, L. Turnbull, C. T. January, J. Sharkey, and J. S. Kelly, “[3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen,” European Journal of Pharmacology, vol. 430, no. 1, pp. 147–148, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Chopra, M. Saluja, G. Tillu et al., “Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial,” Rheumatology, vol. 52, no. 8, Article ID ket414, pp. 1408–1417, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. H. Soll, W. M. Weinstein, J. Kurata, and D. McCarthy, “Nonsteroidal anti-inflammatory drugs and peptic ulcer disease,” Annals of Internal Medicine, vol. 114, no. 4, pp. 307–319, 1991. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Xie, D. L. Robertson, and D. L. Simmons, “Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal antiinflammatory drugs,” Drug Development Research, vol. 25, no. 4, pp. 249–265, 1992. View at Publisher · View at Google Scholar · View at Scopus
  37. J. R. Vane, “Towards a better aspirin,” Nature, vol. 367, no. 6460, pp. 215–216, 1994. View at Publisher · View at Google Scholar · View at Scopus
  38. R. V. Frolov, I. I. Ignatova, and S. Singh, “Inhibition of hERG potassium channels by celecoxib and its mechanism,” PLoS ONE, vol. 6, no. 10, Article ID e26344, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. ICH Harmonized Tripartite Guideline E14, The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs, 2005, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E14/E14_Guideline.pdf.
  40. R. Mukkavilli, S. R. Gundala, C. Yang et al., “Modulation of cytochome P450 metabolism and transport across intestinal epithelial barrier by ginger biophenolics,” PLoS ONE, vol. 9, no. 9, Article ID e108386, 2014. View at Publisher · View at Google Scholar
  41. X.-W. Chen, K. B. Sneed, S.-Y. Pan et al., “Herb-drug interactions and mechanistic and clinical considerations,” Current Drug Metabolism, vol. 13, no. 5, pp. 640–651, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. D. Colombo, L. Lunardon, and G. Bellia, “Cyclosporine and herbal supplement interactions,” Journal of Toxicology, vol. 2014, Article ID 145325, 6 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Li, P. Z. Chen, Q. X. Yue et al., “Pungent ginger components modulates human cytochrome P450 enzymes in vitro,” Acta Pharmacologica Sinica, vol. 34, no. 9, pp. 1237–1242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Frank and M. Unger, “Analysis of frankincense from various Boswellia species with inhibitory activity on human drug metabolising cytochrome P450 enzymes using liquid chromatography mass spectrometry after automated on-line extraction,” Journal of Chromatography A, vol. 1112, no. 1-2, pp. 255–262, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. A. H. Rahmani, M. A. Al Zohairy, S. M. Aly, and M. A. Khan, “Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways,” BioMed Research International, vol. 2014, Article ID 761608, 15 pages, 2014. View at Publisher · View at Google Scholar
  46. H.-Y. Gui, R.-N. Chen, Y. Peng et al., “Curcumin protects against 1-methyl-4-phenylpyridinium ion- and lipopolysaccharide-induced cytotoxicities in the mouse mesencephalic astrocyte via inhibiting the cytochrome P450 2E1,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 523484, 13 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Pimkaew, J. Küblbeck, A. Petsalo et al., “Interactions of sesquiterpenes zederone and germacrone with the human cytochrome P450 system,” Toxicology in Vitro, vol. 27, no. 6, pp. 2005–2012, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Savai, A. Varghese, and N. Pandita, “Lack of the cytochrome P450 3A interaction of methanolic extract of Withania somnifera, Withaferin A, Withanolide A and Withanoside IV,” Journal of Pharmaceutical Negative Results, vol. 4, no. 1, pp. 26–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Rana, S. K. Lattoo, N. Dhar et al., “NADPH-cytochrome P450 reductase: molecular cloning and functional characterizationof two paralogs from Withania somnifera (L.) dunal,” PLoS ONE, vol. 8, no. 2, Article ID e57068, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. S. E. Gabriel, L. Jaakkimainen, and C. Bombardier, “Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: a meta-analysis,” Annals of Internal Medicine, vol. 115, no. 10, pp. 787–796, 1991. View at Publisher · View at Google Scholar · View at Scopus